pVAX1 is specifically designed for use in the development of DNA vaccines. pVAX1 has the following features:
• Eukaryotic DNA sequences limited to those required for expression in order to minimize the possibility of chromosomal integration • Kanamycin resistance gene for selection in E. colibecause ampicillin has been reported to cause an allergic response in some individuals • Expression levels of recombinant proteins from pVAX1 comparable to those achieved with its parent vector, pcDNA™3.1
The small size of pVAX1 and the variety of unique cloning sites simplify subcloning of even very large DNA fragments.
For Research Use Only. Not for use in diagnostic procedures.
Especificações
Constitutive or Inducible System
Constitutive
Delivery Type
Transfection
Promoter
CMV
Product Type
Viral Vaccine Vector
Selection Agent (Eukaryotic)
None
Protein Tag
Untagged
Cloning Method
Restriction Enzyme/MCS
Vector
pVAX1
Product Line
pVAX™
Conteúdo e armazenamento
20 μg of each pVAX1 and expression control vector are supplied supercoiled and lyophilized. Store at -20°C. Vector is guaranteed stable for 6 months when properly stored.
Figuras
Documentos e downloads
Certificados
Pesquisar por número de lote ou número de lote parcial